Charles J. Mullany

Suggest Changes
Learn More
*Chair of 2004 Writing Committee; †Recused from voting on Section 8: Anticoagulants as Ancillary Therapy and Section 10: Anticoagulants; ‡Recused from voting on Section 5: Facilitated PCI; §Canadian(More)
OBJECTIVE The European System for Cardiac Operative Risk Evaluation has been used to define a particularly high-risk group of patients for aortic valve replacement in whom alternative procedures,(More)